{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:23:39Z","timestamp":1793085819282,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006418","name":"Brown University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005196","name":"Chinese Academy of Agricultural Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["R34AA031589"],"award-info":[{"award-number":["R34AA031589"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.conctc.2025.101509","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:38:07Z","timestamp":1749584287000},"page":"101509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Intranasal insulin for the treatment of alcohol use disorder: design and methodology of an alcohol interaction randomized controlled trial"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-5679","authenticated-orcid":false,"given":"Carolina L.","family":"Haass-Koffler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4823-9638","authenticated-orcid":false,"given":"Bhavani","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Gully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sithara S.","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rivkah","family":"Hornbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9093-3792","authenticated-orcid":false,"given":"Stephanie L.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4694-4053","authenticated-orcid":false,"given":"Yuval","family":"Silberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Swift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2847-7949","authenticated-orcid":false,"given":"Leah R.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"William H.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2025.101509_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107454","article-title":"Efficacy of medications for the treatment of alcohol use disorder (AUD): a systematic review and meta-analysis considering baseline AUD severity","author":"Agabio","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.conctc.2025.101509_bib2","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/acer.13431","article-title":"Executive functions, memory, and social cognitive deficits and recovery in chronic alcoholism: a critical review to inform future research","volume":"41","author":"Le Berre","year":"2017","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.conctc.2025.101509_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12934","article-title":"Intranasal insulin","volume":"33","author":"Hallschmid","year":"2021","journal-title":"J. Neuroendocrinol."},{"issue":"Suppl 1","key":"10.1016\/j.conctc.2025.101509_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1360-0443.2006.01586.x","article-title":"The neurobiology of addiction: a neuroadaptational view relevant for diagnosis","volume":"101","author":"Koob","year":"2006","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.conctc.2025.101509_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.conctc.2025.101509_bib6","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/nn1105-1442","article-title":"Plasticity of reward neurocircuitry and the 'dark side' of drug addiction","volume":"8","author":"Koob","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.conctc.2025.101509_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0896-6273(00)80557-7","article-title":"Neuroscience of addiction","volume":"21","author":"Koob","year":"1998","journal-title":"Neuron (Camb., Mass.)"},{"issue":"8","key":"10.1016\/j.conctc.2025.101509_bib8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"10.1016\/j.conctc.2025.101509_bib9","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.psyneuen.2008.08.002","article-title":"Intranasal insulin attenuates the hypothalamic\u2013pituitary\u2013adrenal axis response to psychosocial stress","volume":"33","author":"Bohringer","year":"2008","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"10.1016\/j.conctc.2025.101509_bib10","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.2337\/db14-0477","article-title":"Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men","volume":"63","author":"Heni","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.conctc.2025.101509_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s002130100917","article-title":"How does stress increase risk of drug abuse and relapse?","volume":"158","author":"Sinha","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.conctc.2025.101509_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neubiorev.2018.09.008","article-title":"Addiction and stress: an allostatic view","volume":"106","author":"Koob","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.conctc.2025.101509_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-8587(20)30113-3","article-title":"Central nervous pathways of insulin action in the control of metabolism and food intake","volume":"8","author":"Kullmann","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"170","key":"10.1016\/j.conctc.2025.101509_bib14","doi-asserted-by":"crossref","first-page":"170ra14","DOI":"10.1126\/scitranslmed.3005123","article-title":"Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action","volume":"5","author":"Lindtner","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.conctc.2025.101509_bib15","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3390\/biom5042223","article-title":"Impact of alcohol on glycemic control and insulin action","volume":"5","author":"Steiner","year":"2015","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.conctc.2025.101509_bib16","first-page":"4","article-title":"Addiction and cognition","volume":"5","author":"Gould","year":"2010","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.conctc.2025.101509_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.conctc.2025.101509_bib18","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharmaceut. Sci."},{"issue":"3","key":"10.1016\/j.conctc.2025.101509_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jcbfm.2014.215","article-title":"Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration","volume":"35","author":"Lochhead","year":"2015","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-1998-1102","article-title":"Delivery of nerve growth factor to the brain via the olfactory pathway","volume":"1","author":"Chen","year":"1998","journal-title":"J. Alzheim. Dis."},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ymgme.2012.02.006","article-title":"Lysosomal enzyme can bypass the blood\u2013brain barrier and reach the CNS following intranasal administration","volume":"106","author":"Wolf","year":"2012","journal-title":"Mol. Genet. Metabol."},{"issue":"3","key":"10.1016\/j.conctc.2025.101509_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/jpet.108.149807","article-title":"Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke","volume":"330","author":"Hanson","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.conctc.2025.101509_bib23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1089\/hum.2017.187","article-title":"Intranasal adeno-associated virus mediated gene delivery and expression of human iduronidase in the central nervous system: a noninvasive and effective approach for prevention of neurologic disease in mucopolysaccharidosis type I","volume":"28","author":"Belur","year":"2017","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/rej.2010.1130","article-title":"Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease","volume":"14","author":"Danielyan","year":"2011","journal-title":"Rejuvenation Res."},{"issue":"6","key":"10.1016\/j.conctc.2025.101509_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","article-title":"Intranasal delivery of cells to the brain","volume":"88","author":"Danielyan","year":"2009","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.conctc.2025.101509_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-2094-9-112","article-title":"CAR\/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery","volume":"9","author":"Fransson","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JAD-240484","article-title":"First biodistribution study of [68Ga] Ga-NOTA-Insulin following intranasal administration in adult vervet monkeys","volume":"101","author":"Solingapuram Sai","year":"2024","journal-title":"J. Alzheim. Dis."},{"issue":"4\u20135","key":"10.1016\/j.conctc.2025.101509_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease","volume":"105","author":"Frolich","year":"1998","journal-title":"J. Neural Transm."},{"issue":"4","key":"10.1016\/j.conctc.2025.101509_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pneurobio.2006.06.003","article-title":"Insulin signaling in the central nervous system: learning to survive","volume":"79","author":"van der Heide","year":"2006","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.1016\/j.conctc.2025.101509_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-150307","article-title":"Central nervous system delivery of intranasal insulin: mechanisms of uptake and effects on cognition","volume":"47","author":"Salameh","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.conctc.2025.101509_bib31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/acschemneuro.7b00434","article-title":"Pharmacokinetics of intranasal versus subcutaneous insulin in the mouse","volume":"9","author":"Nedelcovych","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.conctc.2025.101509_bib32","series-title":"Research Societty for Alcohol","article-title":"Alcohol disruption of central control of insulin signaling in short-term exposure models","author":"Silberman","year":"2023"},{"issue":"4","key":"10.1016\/j.conctc.2025.101509_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0091-3057(79)90232-6","article-title":"Endocrine factors contributing to the ethanol preferences of rodents","volume":"10","author":"Goas","year":"1979","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"25\u201326","key":"10.1016\/j.conctc.2025.101509_bib34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.lfs.2011.10.011","article-title":"Insulin attenuates the acquisition and expression of ethanol-induced locomotor sensitization in DBA\/2J mice","volume":"89","author":"Kliethermes","year":"2011","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib35","article-title":"Oxytocin reduces noradrenergic-induced opioid-like withdrawal symptoms in individuals on opioid agonist therapy","volume":"5","author":"Gully","year":"2025","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"10.1016\/j.conctc.2025.101509_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40268-020-00296-2","article-title":"Double-blind placebo-controlled pilot investigation of the safety of a single dose of rapid-acting intranasal insulin in down syndrome","volume":"20","author":"Rosenbloom","year":"2020","journal-title":"Drugs R&D"},{"key":"10.1016\/j.conctc.2025.101509_bib37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40266-021-00845-7","article-title":"A phase II, single-center, randomized, double-blind, placebo-controlled study of the safety and therapeutic efficacy of intranasal glulisine in amnestic mild cognitive impairment and probable mild Alzheimer's disease","volume":"38","author":"Rosenbloom","year":"2021","journal-title":"Drugs Aging"},{"key":"10.1016\/j.conctc.2025.101509_bib38","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s40263-014-0214-y","article-title":"A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild\u2013moderate Alzheimer's disease","volume":"28","author":"Rosenbloom","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.conctc.2025.101509_bib39","series-title":"Alcoholism: Developing Drugs for Treatment","author":"Guidance","year":"2015"},{"issue":"2","key":"10.1016\/j.conctc.2025.101509_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0269881117746904","article-title":"Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET 73 with alcohol: a translational study in rats and humans","volume":"32","author":"Haass-Koffler","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.conctc.2025.101509_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.dib.2017.09.018","article-title":"Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parameters","volume":"15","author":"Haass-Koffler","year":"2017","journal-title":"Data Brief"},{"key":"10.1016\/j.conctc.2025.101509_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejps.2017.07.031","article-title":"A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers","volume":"109","author":"Haass-Koffler","year":"2017","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00213-021-06008-1","article-title":"An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder","volume":"239","author":"Haass-Koffler","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.conctc.2025.101509_bib44","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/acer.15470","article-title":"Probenecid as a pharmacotherapy for alcohol use disorder: a randomized placebo-controlled alcohol interaction trial","volume":"48","author":"Hornbacher","year":"2024","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"9","key":"10.1016\/j.conctc.2025.101509_bib45","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1007\/s00415-022-11119-6","article-title":"MemAID: memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial","volume":"269","author":"Novak","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.conctc.2025.101509_bib46","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnins.2015.00204","article-title":"Aberrant insulin signaling in Alzheimer's disease: current knowledge","volume":"9","author":"Bedse","year":"2015","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.conctc.2025.101509_bib47","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.conctc.2025.101509_bib48","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1523\/JNEUROSCI.3779-10.2011","article-title":"Insulin modulates cocaine-sensitive monoamine transporter function and impulsive behavior","volume":"31","author":"Schoffelmeer","year":"2011","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.conctc.2025.101509_bib49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1530-0277.2010.01334.x","article-title":"Role of feeding\u2010related pathways in alcohol dependence: a focus on sweet preference, NPY, and ghrelin","volume":"35","author":"Leggio","year":"2011","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"9","key":"10.1016\/j.conctc.2025.101509_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.140","article-title":"Leptin levels are reduced by intravenous ghrelin administration and correlated with cue-induced alcohol craving","volume":"5","author":"Haass-Koffler","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.conctc.2025.101509_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw048","article-title":"Serum insulin levels are reduced by intravenous ghrelin administration but do not correlate with alcohol craving in alcohol-dependent individuals","volume":"19","author":"Haass-Koffler","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41398-020-0756-3","article-title":"Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study","volume":"10","author":"Farokhnia","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.conctc.2025.101509_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.alcohol.2023.08.012","article-title":"Evaluating the readability of online patient-facing resources for alcohol use disorder","volume":"115","author":"Soliman","year":"2024","journal-title":"Alcohol"},{"key":"10.1016\/j.conctc.2025.101509_bib54","first-page":"1","article-title":"Structured clinical interview for the DSM (SCID)","author":"First","year":"2014","journal-title":"The encyclopedia of clinical psychology"},{"issue":"9","key":"10.1016\/j.conctc.2025.101509_bib55","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.conctc.2025.101509_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214364","article-title":"Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: a double-blinded placebo-controlled pilot study","volume":"14","author":"Novak","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.conctc.2025.101509_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/alcalc\/agaf013","article-title":"Evaluating the age of individuals who are seeking treatment for alcohol and substance use disorder in a community-based recovery center","volume":"60","author":"Rhew","year":"2025","journal-title":"Alcohol Alcohol"},{"issue":"10","key":"10.1016\/j.conctc.2025.101509_bib58","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/acer.14428","article-title":"Differences in sociodemographic and alcohol-related clinical characteristics between treatment seekers and nontreatment seekers and their role in predicting outcomes in the COMBINE study for alcohol use disorder","volume":"44","author":"Haass-Koffler","year":"2020","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"12","key":"10.1016\/j.conctc.2025.101509_bib59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.15288\/jsas.1994.s12.70","article-title":"Ensuring balanced distribution of prognostic factors in treatment outcome research","author":"Stout","year":"1994","journal-title":"J. Stud. Alcohol Suppl."},{"issue":"7","key":"10.1016\/j.conctc.2025.101509_bib60","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/dom.13279","article-title":"Safety of intranasal human insulin: a review","volume":"20","author":"Schmid","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"Pt B","key":"10.1016\/j.conctc.2025.101509_bib61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cct.2015.08.011","article-title":"Position on zinc delivery to olfactory nerves in intranasal insulin phase I-III clinical trials","volume":"45","author":"Hamidovic","year":"2015","journal-title":"Contemp. Clin. Trials"},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/jc.2017-01976","article-title":"Dose-dependent effects of intranasal insulin on resting-state brain activity","volume":"103","author":"Kullmann","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.conctc.2025.101509_bib64","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s12630-021-01969-5","article-title":"Intranasal administration of 40 and 80 units of insulin does not cause hypoglycemia during cardiac surgery: a randomized controlled trial","volume":"68","author":"Roque","year":"2021","journal-title":"Can. J. Anaesth."},{"issue":"7","key":"10.1016\/j.conctc.2025.101509_bib65","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41366-022-01115-1","article-title":"The effect of intranasal insulin on appetite and mood in women with and without obesity: an experimental medicine study","volume":"46","author":"Schneider","year":"2022","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.conctc.2025.101509_bib66","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuroimage.2019.03.050","article-title":"Modulation of midbrain neurocircuitry by intranasal insulin","volume":"194","author":"Edwin Thanarajah","year":"2019","journal-title":"Neuroimage"},{"issue":"7","key":"10.1016\/j.conctc.2025.101509_bib67","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13288","article-title":"Mifepristone as a pharmacological intervention for stress-induced alcohol craving: a human laboratory study","volume":"28","author":"Haass-Koffler","year":"2023","journal-title":"Addict. Biol."},{"issue":"10","key":"10.1016\/j.conctc.2025.101509_bib68","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1360-0443.2004.00805.x","article-title":"Alcohol impairment of behavior in men and women","volume":"99","author":"Fillmore","year":"2004","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.conctc.2025.101509_bib69","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1037\/1064-1297.11.3.228","article-title":"Dissociative antagonistic effects of caffeine on alcohol-induced impairment of behavioral control","volume":"11","author":"Marczinski","year":"2003","journal-title":"Exp. Clin. Psychopharmacol"},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib70","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1037\/1064-1297.11.1.110","article-title":"Preresponse cues reduce the impairing effects of alcohol on the execution and suppression of responses","volume":"11","author":"Marczinski","year":"2003","journal-title":"Exp. Clin. Psychopharmacol"},{"issue":"4","key":"10.1016\/j.conctc.2025.101509_bib71","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/acer.12658","article-title":"Effects of idazoxan on alcohol pharmacokinetics and intoxication: a preliminary human laboratory study","volume":"39","author":"Haass-Koffler","year":"2015","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib72","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1530-0277.1993.tb00739.x","article-title":"Development and validation of the biphasic alcohol effects scale","volume":"17","author":"Martin","year":"1993","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.conctc.2025.101509_bib73","series-title":"Prospective Person Memory in the Case of Missing Persons: A Coffee Shop Study","author":"Bascom","year":"2022"},{"key":"10.1016\/j.conctc.2025.101509_bib74","article-title":"Wechsler adult intelligence scale","author":"Wechsler","year":"1955","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"9","key":"10.1016\/j.conctc.2025.101509_bib75","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1360-0443.2005.01125.x","article-title":"Cognitive biases toward alcohol\u2010related words and executive deficits in polysubstance abusers with alcoholism","volume":"100","author":"No\u00ebl","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.conctc.2025.101509_bib76","series-title":"Alcohol Craving Questionnaire, Short-form (Revised; ACQ-SF-R): Background, Scoring, and Administration","author":"Singleton","year":"1995"},{"issue":"4","key":"10.1016\/j.conctc.2025.101509_bib77","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1037\/0021-843X.109.4.738","article-title":"Naltrexone's effects on reactivity to alcohol cues among alcoholic men","volume":"109","author":"Rohsenow","year":"2000","journal-title":"J. Abnorm. Psychol."},{"issue":"5","key":"10.1016\/j.conctc.2025.101509_bib78","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/npp.2008.78","article-title":"Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals","volume":"34","author":"Sinha","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.conctc.2025.101509_bib79","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1037\/0033-2909.130.3.355","article-title":"Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research","volume":"130","author":"Dickerson","year":"2004","journal-title":"Psychol. Bull."},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib80","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.conctc.2025.101509_bib81","series-title":"State-Trait Anxiety Inventory, Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1970"},{"key":"10.1016\/j.conctc.2025.101509_bib82","article-title":"Mifepristone as a pharmacological intervention for stress-Induced alcohol craving: a translational randomized tria","author":"Haass-Koffler","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.conctc.2025.101509_bib83","series-title":"Principles of Medical Statistics","author":"Hill","year":"1961"},{"key":"10.1016\/j.conctc.2025.101509_bib84","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1192\/bjp.174.4.297","article-title":"Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials","volume":"174","author":"Bollini","year":"1999","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.conctc.2025.101509_bib85","doi-asserted-by":"crossref","first-page":"663","DOI":"10.15288\/jsa.2005.66.663","article-title":"Acute tolerance to alcohol effects on inhibitory and activational mechanisms of behavioral control","volume":"66","author":"Fillmore","year":"2005","journal-title":"J. Stud. Alcohol"},{"issue":"4","key":"10.1016\/j.conctc.2025.101509_bib86","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40263-014-0149-3","article-title":"Pharmacological approaches to reducing craving in patients with alcohol use disorders","volume":"28","author":"Haass-Koffler","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.conctc.2025.101509_bib87","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fpsyt.2013.00086","article-title":"Bacchus by caravaggio as the visual diagnosis of alcohol use disorder from the fifth edition of the diagnostic and statistical manual of mental disorders (DSM-5)","volume":"4","author":"Haass-Koffler","year":"2013","journal-title":"Front Psychiatry"},{"issue":"2","key":"10.1016\/j.conctc.2025.101509_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2649","article-title":"Learning and memory performance following acute intranasal insulin administration in abstinent smokers","volume":"33","author":"Hamidovic","year":"2018","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"10","key":"10.1016\/j.conctc.2025.101509_bib89","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/mp.2016.234","article-title":"Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial","volume":"22","author":"Hamidovic","year":"2017","journal-title":"Mol. Psychiatr."},{"issue":"7","key":"10.1016\/j.conctc.2025.101509_bib90","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/S1470-2045(16)30223-6","article-title":"Adverse event development in clinical oncology trials","volume":"17","author":"Schmoor","year":"2016","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.conctc.2025.101509_bib91","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/15563650.2017.1296576","article-title":"A systematic review of the evidence for acute tolerance to alcohol - the \"Mellanby effect\"","volume":"55","author":"Holland","year":"2017","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.conctc.2025.101509_bib92","series-title":"Alcohol: its Absorption into and Disappearance from the Blood under Different Conditions","author":"Mellanby","year":"1919"},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib93","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2466\/pms.2003.97.1.21","article-title":"Reliability of a computerized assessment of psychomotor performance and its sensitivity to alcohol-induced impairment","volume":"97","author":"Fillmore","year":"2003","journal-title":"Percept. Mot. Skills"},{"key":"10.1016\/j.conctc.2025.101509_bib94","unstructured":"Frey, I.W.H., Neurologic Agents for Nasal Administration to the Brain 1991, US Patent WIPO."},{"key":"10.1016\/j.conctc.2025.101509_bib95","series-title":"Method for Administering Neurologic Agents to the Brain","author":"Frey","year":"1997"},{"key":"10.1016\/j.conctc.2025.101509_bib96","series-title":"Method for Administering Insulin to the Brain","author":"Frey","year":"2001"},{"issue":"9","key":"10.1016\/j.conctc.2025.101509_bib97","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2337\/db12-0025","article-title":"Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans","volume":"61","author":"Jauch-Chara","year":"2012","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.conctc.2025.101509_bib98","first-page":"638","article-title":"2nd","volume":"201","author":"Frey","year":"2013","journal-title":"Intranasal insulin to treat and protect against posttraumatic stress disorder. J Nerv Ment Dis"},{"issue":"3","key":"10.1016\/j.conctc.2025.101509_bib99","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/ejn.14291","article-title":"Insulin in the ventral tegmental area reduces cocaine-evoked dopamine in the nucleus accumbens in vivo","volume":"50","author":"Naef","year":"2019","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13311-019-00822-4","article-title":"Intranasal insulin: a treatment strategy for addiction","volume":"17","author":"Kashyap","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"9","key":"10.1016\/j.conctc.2025.101509_bib101","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.conctc.2025.101509_bib102","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40266-021-00845-7","article-title":"A phase II, single-center, randomized, double-blind, placebo-controlled study of the safety and therapeutic efficacy of intranasal glulisine in amnestic mild cognitive impairment and probable mild Alzheimer's disease","volume":"38","author":"Rosenbloom","year":"2021","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.conctc.2025.101509_bib103","doi-asserted-by":"crossref","first-page":"240","DOI":"10.14283\/jpad.2021.14","article-title":"Intranasal insulin reduces white matter hyperintensity progression in association with improvements in cognition and CSF biomarker profiles in mild cognitive impairment and alzheimer's disease","volume":"8","author":"Kellar","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.conctc.2025.101509_bib104","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40268-020-00296-2","article-title":"Double-blind placebo-controlled pilot investigation of the safety of a single dose of rapid-acting intranasal insulin in down syndrome","volume":"20","author":"Rosenbloom","year":"2020","journal-title":"Drugs R&D"},{"issue":"12","key":"10.1016\/j.conctc.2025.101509_bib106","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s40263-014-0214-y","article-title":"A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild\u2013moderate Alzheimer's disease","volume":"28","author":"Rosenbloom","year":"2014","journal-title":"CNS Drugs"},{"issue":"16","key":"10.1016\/j.conctc.2025.101509_bib107","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135412","article-title":"Insulin synthesized in the paraventricular nucleus of the hypothalamus regulates pituitary growth hormone production","volume":"5","author":"Lee","year":"2020","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.conctc.2025.101509_bib108","article-title":"Central insulin action induces activation of paraventricular oxytocin neurons to release oxytocin into circulation","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865425000833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865425000833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:08:11Z","timestamp":1762625291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865425000833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":108,"alternative-id":["S2451865425000833"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2025.101509","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal insulin for the treatment of alcohol use disorder: design and methodology of an alcohol interaction randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2025.101509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101509"}}